Clinical trial

A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia…

NCT00208000 · China Medical University Hospital, Other · Unknown status

Key facts

NCT number NCT00208000
Title A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.
Lead sponsor China Medical University Hospital, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions "Hyperuricemia, Anserine"
Intervention type Drug
Interventions Marine active
Start date Jul 1, 2004
Completion Apr 1, 2006
First posted Sep 21, 2005
Last update posted Nov 29, 2010
Countries Taiwan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies